Action
EGFR
Approval Jurisdiction
2014 China, India
Approved for clinical use
cell carcinomas of the head and neck
CAS
780758-10-3
Commercial Vendor
Biotech Pharm.
Compound Image
Nimotuzumab.png
Compound name
Nimotuzumab
Reference
Reference 2
Approved Drug List
1